Recent Updates
Recently added Catalysts
IMRX Positive Sentiment

Kyra Liebson

Saturday, December 27, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Kyra Liebson is a dual-degree holder with a Bachelor of Science in Cell and Molecular Biology from the University of South Florida and a Bachelor of Science in Marketing from SUNY Oswego. She has researched B-cell lymphoma proliferation and has a strong background in marketing and advertising. Liebson's commitment to excellence and passion for science and operations contribute to her role at Immuneering.
Price reaction · baseline $6.73 (2025-12-26 close) · 27 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Kyra Liebson has a strong educational background in science.
  • She combines her scientific knowledge with marketing expertise.
  • Her passion for science and operations enhances her contributions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor

Full Press Release Details

Kyra Liebson holds a Bachelor of Science degree in Cell and Molecular Biology from the University of South Florida. At USF she researched the effects of sodium saccharin on B-cell lymphoma proliferation in A20 cells. She also holds a Bachelor of Science degree in Marketing from SUNY Oswego, and has an extensive background in marketing and advertising. Ms. Liebson has a passion for science, music, and operations and brings her research skillset, diligent work ethic, and a commitment to excellence to her work at Immuneering.

Frequently Asked Questions

What degrees does Kyra Liebson hold?

Kyra Liebson holds a Bachelor of Science in Cell and Molecular Biology and another in Marketing.

What research did Kyra Liebson conduct?

She researched the effects of sodium saccharin on B-cell lymphoma proliferation.

What is Kyra Liebson's role at Immuneering?

She brings her research skills and marketing background to her work at Immuneering.

What are Kyra Liebson's passions?

She has a passion for science, music, and operations.

ShareAdd on Google
Tags: IMRX Viatris Investor Conferences Healthcare Immuneering Cell Biology B-cell lymphoma Marketing Research
Last updated: Dec 27, 2025

Biotech snapshot

Cash runway
$202M liquidity · $6M/mo burn
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 MonotherapyPhase 1
Advanced Solid Tumor →

Catalyst track record

+41%
best trade around IMRX's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for IMRX.

See every catalyst's timing & PoA →